GlassScriptPhysician profile
Carolyn Chambers
NPI 1639151715
$602.33
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $145 · 2020: $37.03 · 2021: $91.30 · 2022: $15.10 · 2023: $193 · 2024: $121.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $314.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $314.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $114.65 | 2019-2023 | Orilissa, Lo Loestrin Fe, Liletta |
| Astellas Pharma US INC | $113.51 | 2023-2024 | Veozah |
| Baxter Healthcare | $77.15 | 2019-2024 | Perclot |
| Pfizer INC. | $53.05 | 2019-2021 | |
| Exeltis, USA INC. | $34.18 | 2020-2023 | Slynd |
| Organon LLC | $31.93 | 2023 | Nexplanon |
| Shield Therapeutics INC | $31.47 | 2023 | Accrufer |
| Mayne Pharma Commercial LLC | $24.45 | 2024 | |
| Coloplast Corp | $21.93 | 2023 | Altis |
| Conmed Corporation | $15.91 | 2020 | |
| Merck Sharp & Dohme LLC | $15.54 | 2024 | Gardasil, Gardasil 9 |
| Therapeuticsmd, INC. | $15.10 | 2022 | |
| Mylan Pharmaceuticals INC. | $14.43 | 2021 | |
| Hologic Sales and Service, LLC | $13.74 | 2019 | |
| Mallinckrodt Enterprises LLC | $13.14 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lupin INC. | $12.15 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carolyn Chambers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.